Clinical Parameters Predicting Unsatisfactory Cervicovaginal Cytology in Conventional Smears
NCT00985309 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2009-09-28
Summary
According the terminology of Bethesda 2001, the unsatisfactory cervical cytology can be categorized into specimen rejected, or specimen processed and examined, but unsatisfactory for evaluation of epithelial abnormality. Most of the unsatisfactory cervical cytology was due to scanty epithelial cells, which was defined by less than an estimated 8,000 to 12,000 well-visualized squamous cells for conventional smears. Follow-up of unsatisfactory smear found an increased rate of cervical preinvasive and invasive lesions. Thus, an unsatisfactory smear deserves careful follow-up and studies. Although the Bethesda system allows criteria modification in cases of hysterectomy, pelvic irradiation therapy, or chemotherapy, no studies investigated the clinical factors related to the incidence of unsatisfactory smear. Thus, the investigators designed this trial to study the clinical factors relating to unsatisfactory cervicovaginal smear.The list of patients who received Papanicolaou smear between March 2006 and August 2006 in our hospital will be obtained from the Pathological Department first. Then the investigators will review the medical records from HIS system and pathologic files of these patients. On estimation, 7,437 cases will be enrolled for analysis. Clinical parameters for analysis include: age, gravidity, parity, abortion, menopause, location of Pap smear, history of pelvic malignancy, pelvic irradiation, cervical conization, hysterectomy; at pregnancy; three months postpartum; vaginal bleeding, vaginal abnormal discharge, intrauterine device, and cervical polyp found during pelvic examinations. Patients who missed any of above data will be excluded for analysis. The investigators will use univariate and multivariate analysis for data processing and statistic analysis to find out the relationship between clinical parameters and unsatisfactory cervicovaginal Pap smears.
Conditions
- Unsatisfactory Pap Smear
Sponsors & Collaborators
-
Taichung Veterans General Hospital
lead OTHER
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- Taiwan
Study Locations
More Related Trials
-
Comparisons of the Effects and Clinical Outcomes of CH2 Vaginal Gel Versus Placebo on CIN1
NCT06582004 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Risk Factors for Concurrent Endometrial Carcinoma in Patients With a Curettage Diagnosis of Endometrial Hyperplasia
NCT01273636 ·Status: UNKNOWN
-
Measurement of Digital Colposcopy for Fluorescence Spectroscopy of Cervical Intraepithelial Neoplasia
NCT00513123 ·Status: COMPLETED
-
Predicting Treatment Failure in HSIL Patients with Positive Margins After Conization Via Detection of PAX1 Methylation
NCT06713655 ·Status: NOT_YET_RECRUITING
-
Vaginal Microbiota and Its Association with Pap Smear Results, Human Papillomavirus, Vitamins, and Metabolic Mark
NCT06897800 ·Status: COMPLETED
-
Study of Pap Smears From Patients Enrolled on Clinical Trial GOG-171
NCT00898144 ·Status: UNKNOWN
-
Using a Sheathed Speculum to Visualize and Access the Cervix In Women With Excessive Vaginal Tissue
NCT01409902 ·Status: COMPLETED
-
Post Colposcopy Management of ASC-US and LSIL Pap Tests
NCT03466710 ·Status: COMPLETED ·Phase: NA
-
Ameliorated Pap Tests and Cervical Cancer Screening Participation
NCT06968871 ·Status: RECRUITING ·Phase: NA
-
Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer
NCT01313104 ·Status: WITHDRAWN ·Phase: NA
-
Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia in Patients With An Abnormal Pap Smear
NCT00610662 ·Status: WITHDRAWN
-
The Association Between Cervical Cancer Screening and Cancer Occurrence
NCT01015079 ·Status: UNKNOWN
-
Clinical Studies of Endometrial Cytology and Cervical Methylation Assays in Endometrial Cancer Screening and Fertility-Preservation Evaluation
NCT06672341 ·Status: NOT_YET_RECRUITING
-
High Resolution Digital Imaging of the Uterine Cervix
NCT00941512 ·Status: COMPLETED
-
Cervical Cancer Screening Strategies
NCT05309122 ·Status: UNKNOWN
-
The Association of G9a Protein and the Outcome of Patients With Cervical Cancer
NCT01505751 ·Status: COMPLETED
-
Spectroscopy Versus Standard Care in Cervical Cancer Patients
NCT00529464 ·Status: TERMINATED ·Phase: PHASE3
-
Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results
NCT00004091 ·Status: COMPLETED
-
Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix
NCT05046080 ·Status: RECRUITING
-
DNA Methylation and the Increased Risk of Cervical Cancer Development
NCT06859151 ·Status: NOT_YET_RECRUITING
-
Comparison of Human Papillomavirus Integrated DNA and Messenger RNA in Cervical Neoplasia
NCT02198365 ·Status: COMPLETED
-
Anal HPV Infection and Abnormal Cytology in HIV-infected Women
NCT00933140 ·Status: COMPLETED
-
Reflectance Confocal Imaging in Cervical Cancer Patients
NCT00505726 ·Status: COMPLETED
-
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
NCT00892866 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Cyclooxygenase-2 Expression in Tissue Samples From Patients With a Normal Cervix, Cervical Intraepithelial Neoplasia, or Early Invasive Cervical Cancer
NCT00900081 ·Status: WITHDRAWN